Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.87%
#2 Unipoly Unipoly +41.52%
#3 SAFEcoin SAFEcoin +29.29%
#4 0G 0G +28.37%
#5 Useless Coin Useless Coin +26.89%
#6 Zora Zora +22.15%
#7 Pons Pons +20.75%
#8 Seeker Seeker +20.67%
#9 Dogs Dogs +18.07%
#10 Fake World Assets Fake World Assets +17.63%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Hansa Biopharma AB (publ) Hansa Biopharma AB (publ)

Hansa Biopharma AB (publ)

HNSA
Classifica tra le azioni #13465
Hansa Biopharma AB (publ) is a biopharmaceutical firm dedicated to developing... Hansa Biopharma AB (publ) is a biopharmaceutical firm dedicated to developing immunomodulatory therapies. Leveraging its unique enzyme technology platform, the company targets treatments that facilitate organ transplants and address rare autoimmune conditions driven by immunoglobulin G (IgG), alongside applications in gene therapy and cancer. Its primary drug candidate, Imlifidase, an enzyme therapy designed to cleave antibodies, is currently undergoing Phase 3 clinical trials for use in patients awaiting sensitized kidney transplants and those with anti-GBM antibody disease. Imlifidase is also in Phase 2 trials for treating antibody-mediated kidney transplant rejection and Guillain Barré syndrome. Further pipeline developments include NiceR (Novel immunoglobulin cleaving enzymes for Repeat dosing) for autoimmune diseases, transplantation, and oncology, as well as EnzE (Enzyme based antibody Enhancement) for cancer immunotherapy. Hansa Biopharma also has a preclinical research partnership with argenx BV, exploring the synergistic potential of their respective IgG-modulating technologies. Established in 2007, the company's headquarters are located in Lund, Sweden.
Prezzo delle azioni
$4.83
Capitalizzazione di mercato
$481.23M
Variazione (1 giorno)
-3.01%
Variazione (1 anno)
41.08%
Paese
SE
Scambia Hansa Biopharma AB (publ) (HNSA)

Categoria

Healthcare
Storico dividendi per Hansa Biopharma AB (publ) (HNSA)
Hansa Biopharma AB (publ) (simbolo azionario: HNSA) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Hansa Biopharma AB (publ) (HNSA) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH